Mechanically bonded polymers constitute a class of desirable, yet challenging, synthetic targets in macromolecular science. Among them, polyrotaxanes have captured a considerable amount of attention, not only because of their exotic architectures, but also as a result of their promising applications, including in slide-ring gels, in battery electrode materials, and in drug delivery systems. There are two commonly used synthetic protocols when it comes to making polyrotaxanes. The first one is the “threading-followed-by-stoppering” approach, and the other one is the “threading-followed-by-polymerization” method. In both these instances, the polyrotaxanes are obtained under thermodynamic equilibrium, forming mechanically bonding dumbbells terminated by sterically bulky stoppers. However, there exists a need for new mechanically bonded polymers as well as methods that enable both polymerization and depolymerization of the same.
Disclosed herein are daisy chain polymers and methods of making daisy chain polymers under redox control employing an energy ratchet mechanism using a molecular-pump-containing monomer.
One aspect of the technology provides for daisy chain polymers. The daisy chain polymer may comprise a multiplicity of molecular-pump-containing monomers. The molecular-pump-containing monomers comprise a molecular pump having a recognition site and a Coulombic barrier. In some embodiments, the molecular-pump-containing monomers are kinetically trapped. In some embodiments, the molecular-pump-containing monomers are host-guest paired.
In some embodiments, the molecular-pump-containing monomers further comprise a redox-active macrocyclic component and a collecting chain. In some embodiments, the redox-active macrocyclic component of one molecular-pump-containing monomer is kinetically trapped on the collecting chain of another molecular-pump-containing monomer. In some embodiments, the redox-active macrocyclic component of one molecular-pump containing monomer is host-guest paired with the recognition site of another molecular-pump-containing monomer. In some embodiments, the recognition site comprises a viologen subunit. In some embodiments, the Coulombic barrier comprises a dimethylpyridinium. In some embodiments, the redox-active macrocyclic component comprises a cyclobis(paraquat-p-phenylene) (CBPQT) macrocycle. In some embodiments, the molecular-pump-containing monomers are
In some embodiments, the molecular-pump-containing monomers comprise two molecular pumps and a collecting chain joining the two molecular pumps. The daisy chain polymer may further comprise a multiplicity of macrocyclic monomers. The macrocyclic monomers may comprise two redox-active macrocyclic components and a chain joining the two redox-active macrocyclic components. In some embodiments, the redox-active macrocyclic component of the macrocyclic monomer is kinetically trapped on the collecting chain of the molecular-pump-containing monomer. In some embodiments, the redox-active macrocyclic component of the macrocyclic monomer is host-guest paired with the recognition site of the molecular-pump-containing monomer. In some embodiments, the redox-active macrocyclic component of one molecular-pump containing monomer is host-guest paired with the recognition site of another molecular-pump-containing monomer. In some embodiments, the recognition site comprises a viologen subunit. In some embodiments, the Coulombic barrier comprises a dimethylpyridinium. In some embodiments, the redox-active macrocyclic component comprises a cyclobis(paraquat-p-phenylene) (CBPQT) macrocycle. In some embodiments, the molecular-pump-containing monomers are
In some embodiments, the daisy chain polymer has a degree of polymerization of 3 or greater.
Another aspect of the technology is a composition for preparing a daisy chain polymer. The composition may comprise a plurality of any of the molecular-pump-containing monomers described herein. In some embodiments, the composition further comprises a plurality of any of the macrocyclic monomers described herein.
The daisy chain polymers described herein may be prepared with an energy ratchet mechanism. The method of preparing a daisy chain polymer may comprise reducing a plurality of molecular-pump-containing monomers with a reducing agent, thereby host-guest pairing a multiplicity of molecular-pump-containing monomers. The method may further comprise oxidizing the multiplicity of host-guest paired molecular-pump-containing monomers, thereby kinetically trapping the multiplicity of molecular-pump-containing monomers.
The daisy chain polymers described herein may depolymerized. The method for depolymerizing the daisy chain polymers may comprise oxidizing a multiplicity of host-guest paired molecular-pump-containing monomers with an oxidizing agent, thereby detreading the multiplicity of molecular-pump-containing monomers. The method may further comprise reducing a multiplicity of kinetically trapped molecular-pump-containing monomers to prepare the multiplicity of host-guest paired molecular-pump-containing monomers.
These and other aspects of the invention will be further described herein.
Non-limiting embodiments of the present invention will be described by way of example with reference to the accompanying figures, which are schematic and are not intended to be drawn to scale. In the figures, each identical or nearly identical component illustrated is typically represented by a single numeral. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the invention shown where illustration is not necessary to allow those of ordinary skill in the art to understand the invention.
Herein we disclose a new protocol to synthesis daisy chain polymers employing an energy ratchet mechanism. Daisy chain polymers are a subclass of mechanically bonded polymers or as well as a subclass of polyrotaxanes. Daisy chain polymers may be prepared by harnessing artificial molecular pumps to controllably deliver rings by dint of redox-driven processes. This programmable strategy leads to the precise incorporation of macrocyclic rings onto collecting chains to give rise to mechanically bonded polymers with control over the numbers of mechanical bonds. Importantly, the formation of the mechanically bonded polymers can be independent of the nature of a chosen threading component or collecting chain because of the high operational reliability of molecular pumps.
As demonstrated in the Examples that follow, molecular-pump containing monomers were designed and used to prepare mechanically bonded polymers. The strategy for synthesizing daisy chain polymers utilizing monomers based on molecular pumps operated away-from-equilibrium. The molecular pumps serve as both recognition sites and Coulombic barriers, rather than steric ones. Under different redox states, the molecular pumps enable polymerization as well as depolymerization under redox stimuli.
A “recognition site” or “RS” means a part of the molecular pump at which a macrocyclic component of a rotaxane prefers to locate. A recognition site immobilizes a macrocyclic component with host-guest noncovalent interactions typical of supramolecular chemistry. Suitably, the recognition site may be comprised of radical, ionic, polar, or hydrophobic groups, including any combination thereof. In some embodiments, the recognition site allows for radical pairing with the macrocyclic component. In some embodiments, the RS is a viologen subunit. A “viologen subunit” (V) means a subunit that is substituted or unsubstituted 4,4′-bipyridine, such as C10H8N2. Viologens include 4,4′-bipyridinium (BIPY) subunits.
A “Coulombic barrier” or “CB” means a part of the molecular pump that presents a thermodynamic or kinetic barrier to a macrocyclic component. The thermodynamic or kinetic barrier may depends strongly on the redox state of the Coulombic barrier. Suitably the CB may be a chemical group capable of being in an ionic and/or radical redox state. Exemplary CBs include substituted or unsubstituted heteroaryls, such as 2,6-dimethylpyridinium (PY) or 3,5-dimethylpyridinium.
The recognition site and Columbic barrier may be joined by a linking subunit. In some embodiments, the linking subunit is a trismethylene subunit or bismethylene subunit, but other linking subunits may also be selected. The linking subunit may be selected to alter the association constant Ka of radical recognition pairs.
A “rotaxane” means a molecular assembly comprising at least one molecular component with a linear section threaded through at least one macrocyclic component of another or the same molecular component, and having end-groups capable of preventing dethreading of the macrocyclic component via thermodynamic or kinetic trapping of the macrocyclic component.
A “polyrotaxane” means a polymer composed of macromolecules that are macromolecular rotaxanes. When describing a rotaxane, the number n indicates the total number of independent components of the rotaxane, i.e., n=t+m where t is the total number of threading components and m is the total number of macrocyclic components.
A “macrocyclic component” or “MC” means a molecule that has at least one ring (cycle) large enough to allow it to be threaded onto a linear subchain of another molecule. Macrocyclic components include cyclobis(paraquat-p-phenylene) (CBPQT) in any of its possible redox states such as CBPQT4+, CBPQT·3+, or CBPQT2(·+).
A “threading component” or “TC” means a molecule comprising at least one molecular pump and at least one collecting chain (CC) onto which at least one macrocyclic component is collected. In some embodiments, the TC component comprises one molecular pump. In other embodiments, the TC comprises two molecular pumps.
A “collecting chain” or “CC” is a linear subchain. The CC may be suitably selected from a number of different groups, including alkyl or polyether chains (e.g., polyethylene glycol chains). When the collecting chain is long enough, rotaxanes are highly stable at elevated temperatures over prolonged period of time. For example, when the collecting chain is longer than 11 atoms long, i.e., longer than —CH11H22—, a [2]rotaxane may be highly stable even at 80° C. for hours or longer. A long collecting chain may also make formation of cyclic oligomers unfavorable in the reduced state.
In some embodiments, the collecting chain may also include an aryl group (e.g., a phenylene subunit) and, optionally, a linking subunit (e.g., a trismethylene subunit or bismethylene subunit) between the aryl group and the molecular pump. The aryl group and linking subunit, if present, may be selected to alter the association constant Ka of radical recognition pairs.
In the Examples that follow, the preparation of an AB-type and an AA-type molecular-pump-containing monomers is disclosed. An AB-type molecular-pump-containing monomer comprises a molecular pump (A), a redox-active macrocyclic component (B), and a collecting chain joining the molecular pump and the redox-active macrocyclic component. AB-type monomers may be used to prepare homopolymers where the molecular pump of one monomer is capable of treading through the redox-active macrocyclic component of another monomer.
An AA-type molecular-pump-containing monomer comprises two molecular pumps (A) and a collecting chain joining the two molecular pump. AA-type monomers may be used to prepare copolymers with BB-type monomers, or macrocyclic monomers, where BB-type monomers comprises two redox-active macrocyclic components (B) and a chain joining the two redox-active macrocyclic components. When AA- and BB-type monomers are used, one of the molecular pumps of the AA-type monomer is capable of treading through the redox-active macrocyclic component of a first BB-type monomer and the other molecular pump of the AA-type monomer is capable of treading through the redox-active macrocyclic component of a second BB-type monomer.
As illustrated in the examples, the daisy chain polymer may contain cyclobis(paraquat p-phenylene) (CBPQT4+) rings and molecular pump units composed by a pyridium (PY+) unit and a bipiridinium (BIPY2+) units.
The monomers can undergo dynamic and reversible supramolecular polymerization at reduced conditions because of host-guest pairing interactions, such as radical pairing interactions, between macrocyclic components and the molecular pumps. Upon fast oxidation, the supramolecular polymers can be converted into kinetically trapped daisy chain polymers on account of energy ratchet mechanism. The daisy chain polymers can be switched back to the supramolecular polymer reversibly by reduction, and thus be depolymerized into the monomers using a slow-oxidation protocol to fully recover the monomers.
Compositions comprising a plurality of molecular-pump-containing monomers as described herein may be used to prepare daisy chain polymers comprising a multiplicity of kinetically trapped or host-guest paired molecular-pump-containing monomers. When AA-type molecular-pump-containing monomers, the composition may further comprise a multiplicity BB-type macrocylic monomers to allow for polymerization. In addition, the methods disclosed herein allow for depolymerization of daisy chain polymers into their respective monomers.
As used herein, “multiplicity” is used to denote the degree of polymerization (DP). Suitably, DP is at least 3 but may be more depending on the association constant for the monomers and polymerization conditions employed. In some embodiments, the DP is at least 4, 5, 6, 7, 8, 9, 10, 11, or more. “Plurality” is used to denote the amount of monomers in a solution or other composition. Suitably, the amount of monomers in a composition may be measured on a mole scale (such as pmol, nmol, μmol, mmol, mol, or more), molar scale (such as pM, nM, μM, mM, M, or more), or gram scale (such as pg, ng, μg, mg, g, or more).
The assembly of a kinetically trapped daisy chain polymer under redox control has been achieved with a self-complementary monomer using an energy ratchet mechanism. In the Examples, the monomer is composed of a molecular pump at one end and a cyclobis(paraquat-p-phenylene) (CBPQT4+) ring at the other end, which are linked together by a long collecting chain. When the monomer is reduced to its radical state, it self-assembles into a supramolecular daisy chain polymer on account of radical-pairing interactions between a bipyridinium radical cation (BIPY·+) on the pump head and the CBPQT2(·+) ring. When excess of Ag2SO4 is added quickly to the solution in order to oxidize the BIPY·+ units to BIPY2+ dications, the CBPQT4+ rings are forced to thread onto the collecting chains, forming an out-of-equilibrium, kinetically trapped daisy chain polymer. This polymer can be switched reversibly back to the supramolecular polymer by reduction, followed by depolymerization to afford the monomer as a result of slow oxidation under ambient conditions. The present disclosure allows for preparation of out-of-equilibrium self-assembly systems and opens up new opportunities for the synthesis of mechanically bonded polymers.
The concept of molecular pumping illustrated in
The average degree of polymerization (DP) is related to the association constant (Ka) of the radical recognition pairs and the monomer concentration ([M]0), i.e., DP≈(Ka[M]0)1/2. Portions of the molecular pump or collecting chain may be selected to achieve a higher association constant. A linking unit between the recognition site and the Coulombic barrier is be selected to lead to a higher binding constant.
The dimeric dumbbell DB·6PF6 and monomer M·7PF6 were synthesized and fully characterized by 1H NMR and 1H-1H COSY NMR spectroscopies, as well as by high resolution ESI-mass spectrometry. See Examples. The association constant (Ka) between the molecular pump precursor and CBPQT4+ under reducing condition was determined by Vis/NIR titration and the Ka value was found to be (9.7±1.8)×103 M−1 (
The pumping test was carried out using, in the first instance, DB·6PF6 and CBPQT·4PF6. 3.0 Molar equiv of CBPQT·4PF6 was mixed with DB·6PF6 in MeCN at a concentration of 10 mM in a N2-filled glovebox. Excess of Zn dust was added to the solution to reduce the BIPY2+ units to BIPY·+ radical cations. After stirring at room temp for 10 min, the solution turned a deep purple color, which is characteristic16 of a BIPY·+⊂CBPQT2·+ interaction. Zn Dust was removed by filtration, and excess of Ag2SO4 was added as a solid in one portion to the MeCN solution with stirring, producing a yellow-colored solution. A crude 1H NMR spectrum, which was recorded and analyzed, indicated (
The stability of [3]R·14PF6 was checked by recording its 1H NMR spectrum at 70° C., only to find out that it displayed (
The polymerization of M·7PF6 was conducted (
The lower DP compared with the theoretical value can be ascribed to (i) the fact that the actual Ka value, associated with the radical recognition pairs in the case of self-complementary monomer M·7PF6 may be lower than that observed in the control experiment. (ii) The pumping efficiency of M·7PF6 is unlikely to be 100%, leading to a decrease in the DP. In fact, we observed that the manner in which we conducted the oxidation is important as far as the polymerization is concerned. When the oxidizing agent Ag2SO4 was added in three portions consecutively rather than in one portion quickly, the resulting products showed a much lower DP employing the same concentration of M·7PF6. The crude 1H NMR spectrum displays (
Depolymerization of the daisy chain polymer may be accomplished in a convenient way. Excess of Zn dust was added to the MeCN solution of the daisy chain polymer to reduce it back to its radical form, i.e., the supramolecular polymer. After filtration, the solution was placed under ambient conditions and was slowly oxidized by air diffusion. When the color of the solution turned light yellow, a crude 1H NMR spectrum was recorded and found (
The slow-oxidation induced dissociation is understandable since the oxidation of the trisradical tricationic complex involves the loss of three electrons. When the first electron of the trisradical tricationic complex is extracted by the oxidant, a bisradical tetracationic complex (
The controllable kinetic stability of the daisy chain polymers render them useful in life-time-controllable and recycle polymer materials. The polyelectrolyte nature of the polymers may also render them useful for preparation of membrane materials. There are a number of application for the polymers disclosed herein. The daisy chain polymer as useful in slide-ring gels and in the preparation of materials possess unique mechanical properties.
In summary, we have demonstrated that molecular pumping can be exploited in polymer synthesis, enabling the assembly of a daisy chain polymer out-of-equilibrium by supplying chemical energy in one redox cycle. Notably, this kinetically trapped, mechanically bonded polymer can be switched reversibly to the dynamic supramolecular polymer under reducing conditions. Hence, the polymer can be depolymerized into monomers by relaxing the kinetically trapped polymer to its thermodynamic stable state under redox control.
Unless otherwise specified or indicated by context, the terms “a”, “an”, and “the” mean “one or more.” For example, “a molecule” should be interpreted to mean “one or more molecules.”
As used herein, “about”, “approximately,” “substantially,” and “significantly” will be understood by persons of ordinary skill in the art and will vary to some extent on the context in which they are used. If there are uses of the term which are not clear to persons of ordinary skill in the art given the context in which it is used, “about” and “approximately” will mean plus or minus ≤10% of the particular term and “substantially” and “significantly” will mean plus or minus >10% of the particular term.
As used herein, the terms “include” and “including” have the same meaning as the terms “comprise” and “comprising.” The terms “comprise” and “comprising” should be interpreted as being “open” transitional terms that permit the inclusion of additional components further to those components recited in the claims. The terms “consist” and “consisting of” should be interpreted as being “closed” transitional terms that do not permit the inclusion additional components other than the components recited in the claims. The term “consisting essentially of” should be interpreted to be partially closed and allowing the inclusion only of additional components that do not fundamentally alter the nature of the claimed subject matter.
All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
Preferred aspects of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred aspects may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect a person having ordinary skill in the art to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
All reagents were purchased from commercial suppliers and used without further purification. Compounds 2·2PF6S1, CBPQT·4PF6S2, CBPQT-CC·4PF6S3, 1,10-bis(prop-2-yn-1-yloxy)decaneS4 were prepared according to literature procedures. Thin layer chromatography (TLC) was performed on silica gel 60 F254 (E Merck). Reverse-phase column chromatography (RediSep Rf Gold® Reversed-Phase C18), was carried out using CombiFlash® Automation Systems (Teledyne ISCO). UV/Vis Spectra were recorded at room temperature on a Shimadzu UV-3600 spectrophotometer. Nuclear magnetic resonance (NMR) spectra are recorded on Agilent DD2 500 spectrometers, with working frequencies of 500 MHz for 1H and 125 MHz for 13C nuclei, respectively. Chemical shifts are reported in ppm relative to the signals corresponding to the residual non-deuterated solvents (CD3CN: δH=1.94 ppm and δC=118.26 ppm for 13CN). High-resolution mass spectra (HR-ESI) were measured on a Finnigan LCQ iontrap mass spectrometer.
3·3PF6: Compound 1S5 (180 mg, 0.50 mmol) and 2·2PF6S1 (446 mg, 0.75 mmol) were dissolved in MeCN (10 mL) in a 50-mL round-bottomed flask and stirred under reflux for 48 h. After the solvents were removed in vacuo, the crude product was purified using reverse-phase flash chromatography (C18: H2O/MeCN 0.1% TFA 0-100%), followed using anion exchange from TFA− to PF6− by treating the aqueous fractions with an excess of NH4PF6, resulting in a white precipitate which was collected by centrifugation and washed with H2O several times before being dried in vacuo to afford 3·3PF6 as an off-white solid (327 mg, 71%). 1H NMR (500 MHz, CD3CN, 298 K): δ 8.92 (d, J=7.7, 2H), 8.75 (d, J=7.7, 2H), 8.43 (d, J=7.6, 2H), 8.40 (s, 2H), 8.34 (d, J=7.5, 2H), 8.23 (s, 1H), 7.12 (d, J=8.4, 2H), 6.92 (d, J=8.3, 2H), 4.86 (t, J=7.1, 2H), 4.72 (t, J=7.9, 2H), 4.58 (t, J=7.6, 2H), 4.16 (t, J=4.8, 2H), 3.62 (t, J=4.9, 2H), 3.31 (t, J=7.1, 2H), 2.67 (quint, J=7.7, 2H), 2.53 (s, 6H). 13C NMR (125 MHz, CD3CN, 298 K): δ 158.8, 148.2, 146.7, 146.5, 142.4, 140.4, 131.1, 128.8, 128.4, 127.9, 116.0, 68.0, 64.2, 59.2, 58.6, 51.0, 36.9, 32.6, 18.3. ESI-HRMS for 3·3PF6; Calcd for C30H35F18N6OP3: m/z=785.2150 [M−PF6]+; found: 785.2158.
DB·6PF6: 3·3PF6 (200 mg, 0.21 mmol), 1,10-bis(prop-2-yn-1-yloxy)decaneS4 (25 mg, 0.60 mmol), Cu(MeCN)4PF6 (7.5 mg, 0.020 mmol), sodium ascorbate (4.0 mg, 0.020 mmol), and N,N,N,N″,N″-pentamethyldiethyl-enetriamine (PMDETA) (3.5 mg, 0.020 mmol) were dissolved in DMF (6 mL) in a 20-mL vial. The solution was stirred at room temp under a N2 atmosphere for 24 h. Excess of TBACl was added to the solution and the solids were collected by filtration. The crude product was purified by reverse-phase flash chromatography (C18: H2O/MeCN 0.1% TFA 0-100%), followed by anion exchange from TFA− to PF6− by treating the aqueous fractions with an excess of NH4PF6, resulting in a white precipitate which was collected by centrifugation and washed with H2O several times before being dried in vacuo to afford DB·6PF6 as an off-white solid (176 mg, 82%). 1H NMR (500 MHz, CD3CN, 298 K): δ 8.93 (d, J=7.7, 4H), 8.75 (d, J=7.7, 4H), 8.45 (d, J=7.7, 4H), 8.40 (s, 4H), 8.34 (d, J=7.5, 4H), 8.23 (s, 2H), 7.85 (s, 2H), 7.10 (d, J=8.4, 4H), 6.86 (d, J=8.3, 4H), 4.85 (t, J=7.8, 4H), 4.75-4.72 (m, 4H), 4.58 (t, J=7.6, 4H), 4.53 (s, 4H), 4.39 (t, J=4.8, 4H), 3.48 (t, J=4.9, 4H), 3.28 (t, J=7.1, 4H), 2.70 (quint, J=7.7, 4H), 2.53 (s, 12H), 1.56-1.53 (m, 4H), 1.30-1.28 (m, 12H). 13C NMR (125 MHz, CD3CN, 298 K) δ 158.5, 151.3, 150.7, 148.2, 146.7, 146.5, 145.8, 142.4, 140.4, 131.1, 129.0, 128.4, 128.0, 127.9, 124.9, 124.8, 116.0, 71.0, 67.4, 64.5, 64.4, 64.1, 59.2, 58.6, 50.3, 36.8, 33.5, 32.6, 30.3, 30.2, 30.2, 30.2, 30.1, 30.0, 26.8, 26.6, 24.2, 20.2, 18.3, 13.7. ESI-HRMS for DB·6PF6; Calcd for C76H96F36N12O4P6: m/z=910.3117 [M−2PF6]2+; found: 910.3130.
5·3PF6: Compound 4S5 (250 mg, 0.50 mmol) and 2·2PF6S1 (446 mg, 0.75 mmol) were dissolved in MeCN (10 mL) in a 50-mL round-bottomed flask and stirred under reflux for 48 h. After the solvents were removed in vacuo, the crude product was purified using reverse-phase flash chromatography (C18: H2O/MeCN 0.1% TFA 0-100%), followed by anion exchange from TFA− to PF6− by treating the aqueous fractions with an excess of NH4PF6, resulting in a white precipitate which was collected by centrifugation and washed with H2O several times before being dried in vacuo to afford 5·3PF6 as an off-white solid (385 mg, 73.3%). 1H NMR (500 MHz, CD3CN, 298 K): δ 8.92 (d, J=7.6, 2H), 8.75 (d, J=7.7, 2H), 8.44 (d, J=7.7, 2H), 8.40 (s, 2H), 8.34 (d, J=7.5, 2H), 8.23 (s, 1H), 7.10 (d, J=8.4, 2H), 6.88 (d, J=8.3, 2H), 4.85 (t, J=7.1, 2H), 4.73 (t, J=7.9, 2H), 4.58 (t, J=7.6, 2H), 3.96 (t, J=4.8, 2H), 3.32-3.28 (m, 4H), 2.69 (quint, J=7.7, 2H), 2.53 (s, 6H), 1.75 (quint, J=7.7, 2H), 1.62-1.58 (m, 2H), 1.37-0.98 (m, 16H). 13C NMR (125 MHz, CD3CN, 298 K): δ 159.6, 151.4, 150.7, 148.2, 146.7, 146.5, 142.4, 140.4, 131.0, 128.4, 127.9, 127.9, 118.2, 115.8, 68.8, 64.2, 59.2, 58.6, 52.1, 36.9, 32.5, 30.19, 30.18, 30.15, 30.11, 30.0, 29.9, 29.7, 29.4, 27.3, 26.6, 24.2, 20.2, 18.3, 13.7. ESI-HRMS for 5·3PF6; Calcd for C40H55F18N6O P3: m/z=925.3715 [M−PF6]+; found: 925.3729.
M·7PF6: 5·3PF6 (106 mg, 0.10 mmol), CBPQT-CC·4PF6S4 (127 mg, 0.10 mmol), Cu(MeCN)4PF6 (3.8 mg, 0.010 mmol), sodium ascorbate (2.0 mg, 0.010 mmol), and PMDETA (1.8 mg, 0.010 mmol) were dissolved in DMF (5 mL) in a 20-mL vial. The solution was stirred at room temp under N2 atmosphere for 24 h. Excess of TBACl was added to the solution, and then the solids were collected by filtration. The crude product was purified by reverse-phase flash chromatography (C18: H2O/MeCN 0.1% TFA 0-100%), followed by anion exchange from TFA− to PF6− by treating the aqueous fractions with an excess of NH4PF6, resulting in a white precipitate which was collected by centrifugation and washed with H2O several times before being dried in vacuo to afford M·7PF6 as an off-white solid (189 mg, 81.2%). 1H NMR (500 MHz, CD3CN, 298 K): δ 8.94 (d, J=6.9, 2H), 8.89 (d, J=6.6, 8H), 8.79 (d, J=7.6, 2H), 8.44 (d, J=6.4, 2H), 8.41 (s, 2H), 8.36 (d, J=7.5, 4H), 8.23 (s, 2H), 8.20 (d, J=6.4, 4H), 8.14 (d, J=6.5, 4H), 8.10 (s, 2H), 7.87 (s, 1H), 7.51 (s, 4H), 7.12 (d, J=8.5, 4H), 6.89 (d, J=8.5, 4H), 6.21 (s, 4H), 5.77 (s, 4H), 5.28 (s, 2H), 4.84 (t, J=7.8, 2H), 4.73 (t, J=7.7, 2H), 4.58 (t, J=7.6, 2H), 4.29 (t, J=7.8, 2H), 4.32 (s, 2H), 3.96 (t, J=6.6, 2H), 3.29 (t, J=7.3, 2H), 2.69 (quint, J=7.7, 2H), 2.53 (s, 6H), 1.91 (quint, J=7.7, 2H), 1.76 (quint, J=7.6, 2H), 1.46 (quint, J=7.7, 2H), 1.35-1.32 (m, 14H). 13C NMR (125 MHz, CD3CN, 298 K) δ 167.9, 167.6, 159.6, 151.4, 150.7, 148.2, 146.9, 146.7, 146.5, 146.0, 142.5, 142.4, 140.4, 138.6, 136.9, 134.3, 131.5, 131.04, 130.99, 128.4, 128.4, 128.01, 127.96, 127.9, 125.4, 118.2, 118.0, 115.8, 68.9, 65.5, 64.1, 60.2, 59.6, 59.2, 58.6, 50.9, 40.0, 36.9, 32.6, 30.9, 30.3, 30.3, 30.2, 30.1, 30.0, 29.7, 27.1, 26.7, 18.3. ESI-HRMS for M·7PF6; Calcd for C83H90F42N11O5P7: m/z=1022.7662 [M−2PF6]2+; found: 1022.7672.
[3]R·14PF6: DB·6PF6 (11 mg, 0.10 mmol) and CBPQT·4PF6S2 (12 mg, 0.22 mmol) were dissolved in MeCN (0.40 mL) in a N2-filled glovebox. Excess of Zn dust was added to the solution, and the resulting mixture were stirred at room temp for 10 min. After removing the Zn dust by filtration, excess of Ag2SO4 was added to the deep purple solution under stirring to produce a yellow colored solution. Excess of TBACl was added to the solution, and then the solids were collected by filtration. The crude product was purified by reverse-phase flash chromatography (C18: H2O/MeCN 0.1% TFA 0-100%), followed by anion exchange from TFA− to PF6− by treating the aqueous fractions with an excess of NH4PF6, resulting in a white precipitate which was collected by centrifugation and washed with H2O several times before being dried in vacuo to afford [3]R·14PF6 as an light yellow solid (16 mg, 74%). 1H NMR (500 MHz, CD3CN, 298 K): δ 9.22 (d, J=6.8, 2H), 9.10 (d, J=7.0, 2H), 8.96 (d, J=6.7, 8H), 8.66 (d, J=6.9, 2H), 8.60 (d, J=7.0, 2H), 8.43 (s, 2H), 8.25 (s, 1H), 8.12 (s, 1H), 7.90 (d, J=6.6, 2H), 7.87 (s, 8H), 5.84-5.77 (m, 8H), 5.07 (d, J=8.3, 2H), 4.83 (s, 2H), 4.74 (t, J=5.0, 2H), 4.67-4.60 (m, 4H), 4.75 (t, J=7.0, 2H), 3.36 (t, J=5.0, 2H), 2.95-2.91 (m, 2H), 2.77-2.72 (m, 2H), 2.71 (d, J=8.4, 2H), 2.55 (s, 6H), 1.69 (quint, J=7.5, 2H), 1.37-1.30 (m, 6H). 13C NMR (125 MHz, CD3CN, 298 K) δ 154.9, 151.1, 151.0, 147.9, 147.6, 146.4, 146.2, 145.9, 145.7, 145.5, 142.1, 140.1, 137.7, 131.3, 130.1, 128.3, 128.0, 127.9, 127.9, 127.2, 127.0, 125.7, 112.5, 71.9, 65.8, 65.5, 64.2, 62.2, 50.0, 58.3, 49.7, 35.0, 32.2, 30.1, 30.0, 26.5, 18.0. ESI-HRMS for [3]R·14PF6; Calcd for C148H160F84N20O4P14: m/z=1291.9658 [M−3PF6]3+; found: 1291.9674.
The binding constant of 5·2+⊂CBPQT2(+·) was determine by Vis/NIR titration in MeCN following a previously reported5 protocol in J. Am. Chem. Soc. 2016, 138, 8288-8300.
This application claims benefit of priority to U.S. Patent Application Ser. No. 63/028,894, filed May 22, 2020, the contents of which is incorporated herein by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/070599 | 5/24/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63028894 | May 2020 | US |